2016
DOI: 10.4172/hccr.1000106
|View full text |Cite
|
Sign up to set email alerts
|

Do We Need A Wider Therapeutic Paradigm For Heart Failure With Comorbidities?: A Remote Australian Perspective

Abstract: Forty percent of CHF clients can suffer with up to five or more comorbidity, a rate that is likely higher in the NT. Large CHF trials AbstractCongestive Heart Failure a leading cause of morbidity and mortality is often associated with comorbidities and with it polypharmacy. Improved pathophysiological understanding, the available therapeutics, clinical guidelines and structured programs for comprehensive care have not benefited all clients in the Northern Territory of Australia. The Northern Territory has both… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(24 citation statements)
references
References 88 publications
0
24
0
Order By: Relevance
“…An important area often overlooked is the pill burden, its effects on clients psyche and eventually adherance [24][25][26][27]. Box 2 explores several clinical scenarios not uncommon to the NT.…”
Section: Polypharmacy and Heart Failurementioning
confidence: 99%
“…An important area often overlooked is the pill burden, its effects on clients psyche and eventually adherance [24][25][26][27]. Box 2 explores several clinical scenarios not uncommon to the NT.…”
Section: Polypharmacy and Heart Failurementioning
confidence: 99%
“…This first hurdle usually does not greatly affect strategies that call for increased resources in staffing and infrastructure. As we have previously highlighted this one-dimensional strategy may not however in the long term achieve the programme goals (1,2 Jou rn a l o f Ge ner a l P r a c tic e for community based interventions. An example we highlight here has been in shaping a CDSMP, as part of a CHF disease management programme.…”
Section: Harlan Krumholzmentioning
confidence: 99%
“…These issues becomes more difficult when findings involve implementing a new strategy or if there are more than one choice available. We have previously discussed some of these challenges and potential solutions for the NT [1][2][3][4][5]. In this short commentary, we discuss briefly some issues on the implementation strategies for CHF best practice in the Northern Territory (NT) of Australia and why it remains difficult for the cardiologists who are held to account to also maintain a degree of control on the process.…”
Section: Harlan Krumholzmentioning
confidence: 99%
See 1 more Smart Citation
“…Medication side effects, extra class interactions, and pill burden are poorly factored in RCT or guidelines. 5 , 6 Posttranslational research for evidence to simplify therapeutic regimes or to improve efficacy is also lacking. 5 , 6 …”
Section: Defining Key Areas To Studymentioning
confidence: 99%